High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801.

Kirkwood JM, Ibrahim JG, Sosman JA, Sondak VK, Agarwala SS, Ernstoff MS, Rao U
J Clin Oncol. 2001 19 (9): 2370-80

PMID: 11331315 · DOI:10.1200/JCO.2001.19.9.2370

MeSH Terms (21)

Adult Aged Cancer Vaccines Disease-Free Survival Female G(M2) Ganglioside Hemocyanins Humans Immunoglobulin G Immunoglobulin M Interferon-alpha Interferon alpha-2 Male Melanoma Middle Aged Neoplasm Staging Prospective Studies Recombinant Proteins Saponins Vaccination Vaccines, Conjugate

Connections (1)

This publication is referenced by other Labnodes entities: